Fact CheckerSign in

NCT05704790Completed

Feasibility and Acceptability of Brief, Telehealth Cognitive Compensatory Training for Pediatric Cancer Patients

Feasibility and Acceptability of Brief, Telehealth Cognitive Compensatory Training for Children Treated for Pediatric Cancer

Source: ClinicalTrials.gov · Last updated 3 Sept 2024

Brief summary (registry, in English)

This pilot study will be a prospective, single arm study to investigate the feasibility and acceptability of a brief, telehealth, cognitive compensatory training intervention for children with a history of pediatric cancer at the University of Michigan. Study aims to enroll 10 children with a history of treatment for pediatric cancer, along with their caregiver.

Status (registry)
Completed
Study type
Interventional
Enrollment
26 (actual)
First submitted
9 Jan 2023
Start date
17 Feb 2023
Primary completion date
23 Jul 2024
Lead sponsor
University of Michigan Rogel Cancer Center
NCT number
NCT05704790

What you commit to

  • Study type: Interventional
  • Participants enrolled: 26
  • From 17 Feb 2023 to the primary completion date, 23 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patient has a history of treatment for a pediatric brain tumor
  • Patient has a history of traumatic brain injury or seizures
  • Patient has a history of a developmental disorder (i.e., autism, intellectual disability), behavioral disorder (i.e., oppositional defiant disorder, conduct disorder), or mood disorder (i.e., disruptive mood dysregulation disorder) that would negatively interfere with patient's participation in the intervention.

Who the study is looking for

  • Patient between the ages of 8 and 18
  • Patient has a history of pediatric cancer
  • Patient is at least 6 months posttreatment completion
  • Patient and caregiver are fluent in English, as intervention materials are only available in English at this time.
  • Patient demonstrates deficits in attention and/or executive functioning as evidenced by either (a) performance below one standard deviation on at least one cognitive measure of attention or executive functioning, such as on the Conners Continuous Performance Test (CPT-3), Trail making Test A \& B, Children's Category Test (CCT), and Wisconsin Card Sorting Test (WCST) and/or (b) executive functioning and attention problems are identified during screening with the research assistant.

Age in the registry: 8 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.